Fair Value Calculator Fair Value Calculator
EN DE

MCP (MCP) Fair Value & Analysis

Consumer Defensive · Market cap A$18.7M

M MCP MCP · AU
PriceA$0.1350
Fair ValueA$0.1600
Upside+18.5%
Quality45/100
Watch MCP for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range A$0.1100 – A$0.2000

Fair value as of: Jun 26, 2026

From 7 valuation models · updated 6 days ago

Fair value updated Jun 26, 2026 — revised from A$2.03 to A$0.1600 (−92.1%) since Jun 24, 2026. Share price +8.0% over the past month.

Price vs Fair Value (12 months)

A$0.3300 A$0.1150 Fair Value A$0.1600 Jun 2025 Jul 2026

12‑month range A$0.1150 – A$0.3300 · fair‑value band A$0.1100 – A$0.2000 · the A$0.1350 price screens below the A$0.1600 fair value. As of Jun 26, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

MCP (MCP) currently trades at A$0.1350, while our model-based Fair Value estimate is A$0.1600 — implying the stock looks roughly 18.5% undervalued today. We read business quality at 45/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, MCP generated revenue of A$134M at a net margin of -12.2%. Revenue declined 6.7% year over year. It earns a return on equity of -21.9%. The balance sheet holds a net cash position of A$2.2M. Fundamentals as of Jun 26, 2026

Key figures & financial health

Revenue (TTM) A$134M
Revenue growth (YoY) -6.7%
Net margin -12.2%
Return on equity -21.9%
Free cash flow A$1.6M FY2025
Operating margin -1.1%
More key figures
EPS (TTM) A$-0.1200
EPS growth (YoY) +1,000%
Net cash A$2.2M FY2025

Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

MCP reported revenue of A$139M in FY2025 versus A$200M in FY2021, a compound −8.8%/yr. Reported net income was −A$15.0M in FY2025.

Revenue −8.8%/yr
FY21 A$200M
FY22 A$214M
FY23 A$155M
FY24 A$145M
FY25 A$139M
Net income
FY21 −A$5.4M
FY22 A$333K
FY23 −A$5.1M
FY24 −A$16.0M
FY25 −A$15.0M

Is MCP fairly valued? → Check now

Similar stocks

6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).

Stock Price Fair Value vs Fair Value
PG PG 2,590 MXN 108.66 MXN -96%
The Procter & Gamble Company PGCO34 R$53.60 R$29.97 -44%
L'Oréal S.A LRLCF $445.77 $275.67 -38%
Unilever PLC UNLYF $59.34 $46.11 -22%
Colgate-Palmolive Company CPA €79.16 €55.96 -29%
Hindustan Unilever Limited HINDUNILVR ₹2,185 ₹1,000 -54%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is MCP (MCP) undervalued?
As of Jun 26, 2026, our model estimates a fair value of A$0.1600 versus a price of A$0.1350 — about +19% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MCP?
Our model-based fair value for MCP is A$0.1600 (as of Jun 26, 2026), built from audited fundamentals. The current price is A$0.1350.
What is the quality score of MCP?
MCP has a Quality Score of 45/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of MCP (MCP)?
MCP reported trailing-twelve-month revenue of about A$134M (latest available figure, as of Jun 26, 2026).
What is the net profit margin of MCP?
The net profit margin of MCP is about -12.2%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.